Abstract

BACKGROUND: Identifying mental health disorders, including body dysmorphic disorder (BDD), is important prior to rhinoplasty surgery, however, these disorders are underdiagnosed, and screening tools are underutilized in clinical settings.OBJECTIVE: To evaluate the correlation of a rhinoplasty outcomes tool (SCHNOS) with psychiatric screening tools.METHODS: Patients presenting for rhinoplasty consultation were prospectively enrolled and administered mental health instruments to assess depression (PHQ-9), anxiety (GAD-7) and BDD (BDDQ-AS), as well as the SCHNOS rhinoplasty outcomes scale. Convergent validity of SCHNOS scores with these mental health instruments were assessed, as well as calculation of an optimal SCHNOS-C score to screen for BDD.RESULTS: 76 patients were enrolled in the study. The average SCHNOS-O score (SD) was 46.1 (34.0) and average SCHNOS-C score was 61.1 (27.0). Five (7%) patients screened positive for depression, while 24 (32%) patients screened positive for mild, 5 (7%) for moderate, and 4 (5%) for severe anxiety. 24 (32%) patients screened positive for BDD by BDDQ-AS scores. SCHNOS-O and SCHNOS-C did not correlate with PHQ-9 or GAD-7 scores; SCHNOS-C did correlate with BDDQ-AS. A score of 73 or greater on SCHNOS-C maximized the sensitivity and specificity of also screening positive for BDD with BDDQ-AS. This score correlated with a sensitivity of 62.5%, specificity of 80.8%, and number needed to diagnose of 2.3, meaning for every 2 patients with a score of =73 on SCHNOS-C, one will have a positive BDDQ-AS score.CONCLUSIONS: SCHNOS-C correlates with BDDQ-AS and may help screen rhinoplasty patients at higher risk for BDD.

View details for DOI 10.1093/asj/sjaa004

View details for PubMedID 31917417